Cases & Deals

XOMA establishes global patent portfolio for IL-1 beta antibodies

Clients XOMA Corporation

Jones Day represents XOMA Corporation for their global patent portfolio for antibodies to IL-1 beta, including gevokizumab, for the treatment of a variety of inflammatory diseases and disorders.